| Mismatch repair protein loss as a prognostic and predictive biomarker in breast cancers regardless of microsatellite instability N Fusco, G Lopez, C Corti, C Pesenti, P Colapietro, G Ercoli, G Gaudioso, ... JNCI Cancer Spectrum 2 (4), pky056, 2018 | 67 | 2018 |
| SARS-CoV-2 vaccines for cancer patients: a call to action C Corti, E Crimini, P Tarantino, G Pravettoni, AMM Eggermont, S Delaloge, ... European journal of cancer 148, 316-327, 2021 | 66 | 2021 |
| Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies P Tarantino, R Carmagnani Pestana, C Corti, S Modi, A Bardia, ... CA: A Cancer Journal for Clinicians, 2021 | 66 | 2021 |
| PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine? N Fusco, E Sajjadi, K Venetis, G Gaudioso, G Lopez, C Corti, EG Rocco, ... Genes 11 (7), 719, 2020 | 61 | 2020 |
| Seroconversion rate after vaccination against COVID-19 in patients with cancer -a systematic review C Corti, G Antonarelli, F Scotté, JP Spano, J Barrière, JM Michot, F André, ... Annals of Oncology, 2021 | 55 | 2021 |
| Commentary: SARS-CoV-2 vaccines and cancer patients C Corti, G Curigliano Annals of Oncology, 2021 | 50 | 2021 |
| Immunotherapy for early triple negative breast cancer: research agenda for the next decade P Tarantino, C Corti, P Schmid, J Cortes, EA Mittendorf, H Rugo, ... NPJ Breast Cancer 8 (1), 23, 2022 | 44 | 2022 |
| Therapeutic vaccines for breast cancer: Has the time finally come? C Corti, PPMB Giachetti, AMM Eggermont, S Delaloge, G Curigliano European Journal of Cancer 160, 150-174, 2022 | 44 | 2022 |
| HER2 low, ultra-low, and novel complementary biomarkers: expanding the spectrum of HER2 positivity in breast cancer K Venetis, E Crimini, E Sajjadi, C Corti, E Guerini-Rocco, G Viale, ... Frontiers in Molecular Biosciences, 2022 | 40 | 2022 |
| Therapeutic cancer vaccines revamping: technology advancements and pitfalls G Antonarelli, C Corti, P Tarantino, L Ascione, J Cortes, P Romero, ... Annals of Oncology 32 (12), 1537-1551, 2021 | 31 | 2021 |
| Lymphovascular invasion and extranodal tumour extension are risk indicators of breast cancer related lymphoedema: an observational retrospective study with long-term follow-up M Invernizzi, C Corti, G Lopez, A Michelotti, L Despini, D Gambini, ... BMC cancer 18 (1), 1-12, 2018 | 31 | 2018 |
| Antibody–Drug Conjugates for the Treatment of Breast Cancer C Corti, F Giugliano, E Nicolò, L Ascione, G Curigliano Cancers 13 (12), 2021 | 30 | 2021 |
| Determination of mismatch repair status in human cancer and its clinical significance: does one size fit all? C Corti, E Sajjadi, N Fusco Advances in Anatomic Pathology 26 (4), 270-279, 2019 | 30 | 2019 |
| Targeting brain metastases in breast cancer C Corti, G Antonarelli, C Criscitiello, N Lin U, J Cortes, P Poortmans, ... Cancer Treatment Reviews 103 (102324), 2021 | 26 | 2021 |
| PTEN expression as a complementary biomarker for mismatch repair testing in breast cancer G Lopez, M Noale, C Corti, G Gaudioso, E Sajjadi, K Venetis, D Gambini, ... International Journal of Molecular Sciences 21 (4), 1461, 2020 | 26 | 2020 |
| Sex-based differences in response to anti-PD-1 or PD-L1 treatment in patients with non-small-cell lung cancer expressing high PD-L1 levels. A systematic review and meta … F Conforti, L Pala, E Pagan, C Corti, V Bagnardi, P Queirolo, C Catania, ... ESMO open 6 (5), 100251, 2021 | 25 | 2021 |
| Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives E Nicolò, F Giugliano, L Ascione, P Tarantino, C Corti, SM Tolaney, ... Cancer Treatment Reviews, 102395, 2022 | 24 | 2022 |
| First line treatment of BRAF mutated advanced melanoma: Does one size fit all? F Giugliano, E Crimini, P Tarantino, P Zagami, J Uliano, C Corti, ... Cancer Treatment Reviews 99, 102253, 2021 | 22 | 2021 |
| Benefit of Adjuvant Chemotherapy in Patients with Lobular Breast Cancer: a Systematic Review of the Literature and Metanalysis GC D Trapani, S Gandini, C Corti, E Crimini, F Bellerba, I Minchella, C ... Cancer Treatment Reviews, 2021 | 17 | 2021 |
| Bystander effect of antibody-drug conjugates: fact or fiction? F Giugliano, C Corti, P Tarantino, F Michelini, C G Current Oncology Reports, 2022 | 16 | 2022 |
